557 related articles for article (PubMed ID: 8138959)
1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
4. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
7. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
[TBL] [Abstract][Full Text] [Related]
8. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
Goldman DW; Goetzl EJ
J Immunol; 1982 Oct; 129(4):1600-4. PubMed ID: 6286770
[TBL] [Abstract][Full Text] [Related]
12. Effect of leukotriene B4 on enhancement of superoxide production evoked by formyl-methionyl-leucyl-phenylalanine in myeloid differentiated HL-60 cells: possible involvement of intracellular calcium influx and high affinity receptor for leukotriene B4.
Harada Y
Hiroshima J Med Sci; 1990 Sep; 39(3):89-94. PubMed ID: 2178158
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Brom J; Schönfeld W; König W
Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
[TBL] [Abstract][Full Text] [Related]
15. LTB4 induced activation signals and responses in neutrophils are short-lived compared to formylpeptide.
Omann GM; Traynor AE; Harris AL; Sklar LA
J Immunol; 1987 Apr; 138(8):2626-32. PubMed ID: 3031161
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the bidirectional effects of protein kinase C activators on neutrophil responses to leukotriene B4.
O'Flaherty JT; Redman JF; Jacobson DP
J Immunol; 1990 Mar; 144(5):1909-13. PubMed ID: 2155269
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
Jackson RH; Morrissey MM; Sills MA; Jarvis MF
J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release.
Kanaho Y; Kanoh H; Saitoh K; Nozawa Y
J Immunol; 1991 May; 146(10):3536-41. PubMed ID: 1851192
[TBL] [Abstract][Full Text] [Related]
19. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells.
Winkler JD; Sarau HM; Foley JJ; Mong S; Crooke ST
J Pharmacol Exp Ther; 1988 Jul; 246(1):204-10. PubMed ID: 2839662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
